BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 36090336)

  • 21. Short-course radiotherapy combined with CAPOX and Toripalimab for the total neoadjuvant therapy of locally advanced rectal cancer: a randomized, prospective, multicentre, double-arm, phase II trial (TORCH).
    Wang Y; Shen L; Wan J; Zhang H; Wu R; Wang J; Wang Y; Xu Y; Cai S; Zhang Z; Xia F
    BMC Cancer; 2022 Mar; 22(1):274. PubMed ID: 35291966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Systematic review and meta-analysis of preoperative chemoradiotherapy with or without oxaliplatin in locally advanced rectal cancer.
    Zheng J; Feng X; Hu W; Wang J; Li Y
    Medicine (Baltimore); 2017 Mar; 96(13):e6487. PubMed ID: 28353591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
    Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
    [No Abstract]   [Full Text] [Related]  

  • 24. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
    Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
    Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. College of American Pathologists Tumor Regression Grading System for Long-Term Outcome in Patients with Locally Advanced Rectal Cancer.
    Chen HY; Feng LL; Li M; Ju HQ; Ding Y; Lan M; Song SM; Han WD; Yu L; Wei MB; Pang XL; He F; Liu S; Zheng J; Ma Y; Lin CY; Lan P; Huang MJ; Zou YF; Yang ZL; Wang T; Lang JY; Orangio GR; Poylin V; Ajani JA; Wang WH; Wan XB
    Oncologist; 2021 May; 26(5):e780-e793. PubMed ID: 33543577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Total neoadjuvant therapy versus standard neoadjuvant treatment strategies for the management of locally advanced rectal cancer: network meta-analysis of randomized clinical trials.
    Donnelly M; Ryan OK; Ryan ÉJ; Creavin B; O'Reilly M; McDermott R; Kennelly R; Hanly A; Martin ST; Winter DC
    Br J Surg; 2023 Sep; 110(10):1316-1330. PubMed ID: 37330950
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic value of tumour regression grade in locally advanced rectal cancer: a systematic review and meta-analysis.
    Kong JC; Guerra GR; Warrier SK; Lynch AC; Michael M; Ngan SY; Phillips W; Ramsay G; Heriot AG
    Colorectal Dis; 2018 Jul; 20(7):574-585. PubMed ID: 29582537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoadjuvant Short-Course Radiotherapy Followed by Consolidation Chemotherapy before Surgery for Treating Locally Advanced Rectal Cancer: A Systematic Review and Meta-Analysis.
    Liao CK; Kuo YT; Lin YC; Chern YJ; Hsu YJ; Yu YL; Chiang JM; Hsieh PS; Yeh CY; You JF
    Curr Oncol; 2022 May; 29(5):3708-3727. PubMed ID: 35621687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparing real-world outcomes of total neoadjuvant treatment and CRT at a tertiary medical center.
    Turfa R; Alawabdeh T; Naser A; Alamro Y; Albliwi M; Almasri S; Al Qazakzeh A; Shattal MA; Dabous A; Amarin R
    Front Oncol; 2023; 13():1305322. PubMed ID: 38074695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis.
    Ding M; Zhang J; Hu H; Cai Y; Ling J; Wu Z; Xie X; Li J; Li W; Deng Y
    Clin Colorectal Cancer; 2022 Mar; 21(1):e12-e20. PubMed ID: 34963563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Review of Neoadjuvant Chemotherapy Alone in Locally Advanced Rectal Cancer.
    Jalil O; Claydon L; Arulampalam T
    J Gastrointest Cancer; 2015 Sep; 46(3):219-36. PubMed ID: 26133151
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 33. The efficacy and safety of adding bevacizumab in neoadjuvant therapy for locally advanced rectal cancer patients: A systematic review and meta-analysis.
    Zhou Y; Guo Z; Wu Z; Shi J; Zhou C; Sun J; Hidasa I; Lu X; Lu C
    Transl Oncol; 2021 Jan; 14(1):100964. PubMed ID: 33248411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical benefit of adding oxaliplatin to standard neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a meta-analysis : Oxaliplatin in neoadjuvant treatment for rectal cancer.
    De Felice F; Benevento I; Magnante AL; Musio D; Bulzonetti N; Caiazzo R; Tombolini V
    BMC Cancer; 2017 May; 17(1):325. PubMed ID: 28499428
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic Value of Interval Between the Initiation of Neoadjuvant Treatment to Surgery for Patients With Locally Advanced Rectal Cancer Following Neoadjuvant Chemotherapy, Radiotherapy and Definitive Surgery.
    Wan XB; Zhang Q; Chen M; Liu Y; Zheng J; Lan P; He F
    Front Oncol; 2020; 10():1280. PubMed ID: 32974129
    [No Abstract]   [Full Text] [Related]  

  • 36. Is adjuvant chemotherapy necessary for locally advanced rectal cancer patients with pathological complete response after neoadjuvant chemoradiotherapy and radical surgery? A systematic review and meta-analysis.
    Ma B; Ren Y; Chen Y; Lian B; Jiang P; Li Y; Shang Y; Meng Q
    Int J Colorectal Dis; 2019 Jan; 34(1):113-121. PubMed ID: 30368569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presence and clinical significance of acellular mucin pools in resected rectal cancer with pathological complete response after pre-operative chemoradiotherapy.
    Chen M; Lin H; Zhang J; Pang X; Fan X; Luo S; Liu Z; Hu H; Lai S; Hou Y; Kang L; Huang L
    Histopathology; 2022 Nov; 81(5):569-576. PubMed ID: 36104077
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Total neoadjuvant therapy in patients with locally advanced rectal cancer: A tertiary medical center experience.
    Husseini ZE; Haibe Y; Bouferraa Y; Kreidieh M; Darazi MA; Mukherji D; Temraz S; Charafeddine M; Shamseddine A
    Mol Clin Oncol; 2021 Oct; 15(4):220. PubMed ID: 34476104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Total Neoadjuvant Therapy in Rectal Cancer: A Systematic Review and Meta-analysis of Treatment Outcomes.
    Petrelli F; Trevisan F; Cabiddu M; Sgroi G; Bruschieri L; Rausa E; Ghidini M; Turati L
    Ann Surg; 2020 Mar; 271(3):440-448. PubMed ID: 31318794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Total Neoadjuvant Chemotherapy in Rectal Cancer: Current Facts and Future Strategies.
    Beppu N; Ikeda M; Kataoka K; Kimura K; Ikeuchi H; Uchino M; Nakamoto Y; Okamoto R; Yanagi H
    J Anus Rectum Colon; 2023; 7(1):1-7. PubMed ID: 36743465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.